Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06016465

Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?

Does Nerve Block Plus Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hours Better Than Nerve Block Alone?

Status
Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Texas Tech University Health Sciences Center, El Paso · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

For some patients who come to the emergency department for treatment of a migraine headache, peripheral headache nerve blocks (PHNB) have proven to be an efficient and effective treatment for headache relief. Previous studies have demonstrated that adding steroids as an adjunct treatment to standard migraine treatment can reduce recurrence of headaches in the subsequent few days.

Detailed description

Previous studies have provided evidence that administering steroids in addition to standard migraine headache treatment in the emergency department may reduce the recurrence of the headache within 24-72 hours. The standard migraine treatments in previous studies have been varied and include 5-HT receptor agonists, dopamine antagonists, dihydroergotamine, NSAIDS, and opioid analgesics. The steroids added to the standard treatment have been prednisone and dexamethasone (both IV and oral). This is the first study to examine the combination of peripheral nerve block as the primary treatment of migraine followed by oral dexamethasone to prevent recurrence.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone OralTwo 4mg pills
DRUGPlacebo2 placebo pills

Timeline

Start date
2023-09-15
Primary completion
2025-12-30
Completion
2026-01-30
First posted
2023-08-29
Last updated
2025-05-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06016465. Inclusion in this directory is not an endorsement.